Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Caveats about QuantiFERON-TB gold in-tube testing for uveitis.

Literature DB >> 24630206

Caveats about QuantiFERON-TB gold in-tube testing for uveitis.

Kathryn L Pepple¹, Russell Van Gelder², Farzin Forooghian³.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Year: 2014 PMID： 24630206 PMCID： PMC4263814 DOI： 10.1016/j.ajo.2013.12.021

Source DB: PubMed Journal: Am J Ophthalmol ISSN： 0002-9394 Impact factor: 5.258

× No keyword cloud information.

15 in total

Review 1. Uveitis with occult choroiditis due to Mycobacterium kansasii: limitations of interferon-gamma release assay (IGRA) tests (case report and mini-review on ocular non-tuberculous mycobacteria and IGRA cross-reactivity).

Authors: Tatiana I Kuznetcova; Alain Sauty; Carl P Herbort
Journal: Int Ophthalmol Date: 2012-06-02 Impact factor: 2.031

2. Investigation of false-positive results given by the QuantiFERON-TB Gold In-Tube assay.

Authors: Madeline Slater; Julie Parsonnet; Niaz Banaei
Journal: J Clin Microbiol Date: 2012-07-11 Impact factor: 5.948

Review 3. Evidence for mycobacteria in sarcoidosis.

Authors: Isaac Brownell; Francisco Ramírez-Valle; Miguel Sanchez; Stephen Prystowsky
Journal: Am J Respir Cell Mol Biol Date: 2011-06-09 Impact factor: 6.914

4. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research.

Authors: Dick Menzies; Madhukar Pai; George Comstock
Journal: Ann Intern Med Date: 2007-03-06 Impact factor: 25.391

5. Cellular recognition of Mycobacterium tuberculosis ESAT-6 and KatG peptides in systemic sarcoidosis.

Authors: Wonder P Drake; Mary S Dhason; Michele Nadaf; Bryan E Shepherd; Sangeetha Vadivelu; Rana Hajizadeh; Lee S Newman; Spyros A Kalams
Journal: Infect Immun Date: 2006-11-06 Impact factor: 3.441

6. Effects of broad-spectrum antimycobacterial therapy on chronic pulmonary sarcoidosis.

Authors: W P Drake; B W Richmond; K Oswald-Richter; C Yu; J M Isom; J A Worrell; G R Shipley
Journal: Sarcoidosis Vasc Diffuse Lung Dis Date: 2013-11-25 Impact factor: 0.670

7. Prevalence of tuberculosis infection in the United States population: the national health and nutrition examination survey, 1999-2000.

Authors: Diane E Bennett; Jeanne M Courval; Ida Onorato; Tracy Agerton; Judy D Gibson; Lauren Lambert; Geraldine M McQuillan; Brenda Lewis; Thomas R Navin; Kenneth G Castro
Journal: Am J Respir Crit Care Med Date: 2007-11-07 Impact factor: 21.405

8. Initial results of QuantiFERON-TB Gold testing in patients with uveitis.

Authors: S Itty; S J Bakri; J S Pulido; D C Herman; L J Faia; G T Tufty; S R Bennett; N S Falk
Journal: Eye (Lond) Date: 2008-05-02 Impact factor: 3.775

9. Oral antimycobacterial therapy in chronic cutaneous sarcoidosis: a randomized, single-masked, placebo-controlled study.

Authors: Wonder P Drake; Kyra Oswald-Richter; Bradley W Richmond; Joan Isom; Victoria E Burke; Holly Algood; Nicole Braun; Thyneice Taylor; Kusum V Pandit; Caroline Aboud; Chang Yu; Naftali Kaminski; Alan S Boyd; Lloyd E King
Journal: JAMA Dermatol Date: 2013-09 Impact factor: 10.282

Caveats about QuantiFERON-TB gold in-tube testing for uveitis.

Review 1. Uveitis with occult choroiditis due to Mycobacterium kansasii: limitations of interferon-gamma release assay (IGRA) tests (case report and mini-review on ocular non-tuberculous mycobacteria and IGRA cross-reactivity).

2. Investigation of false-positive results given by the QuantiFERON-TB Gold In-Tube assay.

Review 3. Evidence for mycobacteria in sarcoidosis.

4. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research.

5. Cellular recognition of Mycobacterium tuberculosis ESAT-6 and KatG peptides in systemic sarcoidosis.

6. Effects of broad-spectrum antimycobacterial therapy on chronic pulmonary sarcoidosis.

7. Prevalence of tuberculosis infection in the United States population: the national health and nutrition examination survey, 1999-2000.

8. Initial results of QuantiFERON-TB Gold testing in patients with uveitis.

9. Oral antimycobacterial therapy in chronic cutaneous sarcoidosis: a randomized, single-masked, placebo-controlled study.

10. A diagnostic dilemma: infectious versus noninfectious multifocal choroiditis with panuveitis.

1. Splenic tuberculosis and multifocal serpiginoid choroiditis.

2. Structural changes of the choroid in sarcoid- and tuberculosis-related granulomatous uveitis.

3. Serpiginoid choroiditis associated with presumed ocular tuberculosis.

4. What does IGRA testing add to the diagnosis of ocular tuberculosis? A Bayesian latent class analysis.